Skip to content
DefDex

Federal award

WERFEN USA LLC

W81K0222P0068

Contract

Obligated and Ceiling

Obligated (net)
$1,375,480.64
Ceiling (potential value, not spending)
$1,762,064.31
Current value
$1,375,480.64
Gross positive obligations
$1,545,330.65

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
WERFEN USA LLC · JA87HT8KP2M2
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
WERFEN USA LLC · JA87HT8KP2M2
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0222P0068
Award type code
B
Actions
14 · Aug 26, 2022 to Apr 2, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 2, 2026FY2026P00013M$0.00
—
Mar 23, 2026FY2026P00012M$0.00
—
Dec 23, 2025FY2026P00011B$386,583.67
—
Jul 30, 2025FY2025P00010G$0.00
—
Jul 25, 2025FY2025P00009B−$9,553.52
—
Dec 17, 2024FY2025P00008V$0.00
—
Oct 17, 2024FY2025P00007B$386,243.67
—
Sep 13, 2024FY2024P00006B$0.00
—
Jun 21, 2024FY2024P00005B−$160,296.49
—
Oct 11, 2023FY2024P00004C$386,251.68
—
Jun 20, 2023FY2023P00003G$0.00
—
May 17, 2023FY2023P00002M$0.00
—
Oct 24, 2022FY2023P00001C$386,251.63
—
Aug 26, 2022FY20220—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.